Cross-source identity
National Provider Identifier 1093339343 as it appears in every federal dataset Fonteum holds. Each row is a distinct public source; the chip carries the source and the snapshot date behind that field — the record-level form of the source-provenanced graph.
| Federal source | Key | What it provides | Provenance |
|---|
| CMS NPPES | NPI 1093339343 | Registry identity — psychiatrist, taxonomy 2084P0800X | Source:CMS NPPESSnapshot 2026-05-06 |
| CMS Open Payments | NPI 1093339343 | 26 industry-payment records, 2024 | Source:CMS Open PaymentsSnapshot PY2024 |
| CMS Medicare Part D | NPI 1093339343 | 24 drugs prescribed, 2024 | Source:CMS Part DSnapshot DY2024 |
Industry payments
Payments and transfers of value this clinician received from drug and device manufacturers, disclosed under the Physician Payments Sunshine Act. A payment is a disclosure, not a judgment.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,145 | 26 |
| Manufacturer | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals Usa, Inc. | $296 | 4 |
| Alkermes, Inc. | $186 | 4 |
| Neurocrine Biosciences, Inc. | $128 |
Prescribing
Prescriptions written under Medicare Part D, aggregated by drug across the program. Totals reflect claims paid, not patients treated.
| Drug | Claims | Drug cost |
|---|---|---|
| Vyvanse(Lisdexamfetamine Dimesylate) | 13 | $5,567 |
| Aripiprazole | 60 | $1,807 |
| Quetiapine Fumarate | 89 | $1,571 |
| Methylphenidate Er(Methylphenidate Hcl) | 12 | $896 |
| Atomoxetine Hcl | 15 | $838 |
Beneficiary counts below 11 are suppressed by CMS — the total shown is a lower bound.
Quality
CMS Quality Payment Program Merit-based Incentive Payment System (MIPS) final score, where this clinician participated. Absence of a score is not a quality signal — many clinicians report through a group or are exempt.
Enrollment & sanctions
Screening aid — re-confirm any match against the issuing list before acting. A clean result means no record was found in the federal OIG LEIE or the state Medicaid lists Fonteum currently holds (NY, OH, GA), not a guarantee that none exists elsewhere. Not a legal or credentialing certification.
| 4 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $125 | 1 |
| Otsuka America Pharmaceutical, Inc. | $125 | 1 |